Tsz Lun L. Yeung, Ph.D. - Publications

Affiliations: 
MD Anderson Cancer Centre University of Texas, Austin, Texas 
Area:
Ovarian Cancer molecular biology, Transcription factors

0/40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches (unlikely to be authored by this person)
2019 Osmanbeyoglu HU, Shimizu F, Rynne-Vidal A, Alonso-Curbelo D, Chen HA, Wen HY, Yeung TL, Jelinic P, Razavi P, Lowe SW, Mok SC, Chiosis G, Levine DA, Leslie CS. Chromatin-informed inference of transcriptional programs in gynecologic and basal breast cancers. Nature Communications. 10: 4369. PMID 31554806 DOI: 10.1038/S41467-019-12291-6  0.271
2017 Yeung TL, Leung CS, Wong KK, Gutierrez-Hartmann A, Kwong J, Gershenson DM, Mok SC. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells. Oncotarget. PMID 28199976 DOI: 10.18632/Oncotarget.15208  0.268
2019 Hinchcliff E, Paquette C, Roszik J, Kelting S, Stoler MH, Mok SC, Yeung TL, Zhang Q, Yates M, Peng W, Hwu P, Jazaeri A. Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature. Cancer Immunology, Immunotherapy : Cii. PMID 31515669 DOI: 10.1007/s00262-019-02385-x  0.259
2017 Leung CS, Yeung TL, Yip KP, Wong KK, Ho SY, Mangala LS, Sood AK, Lopez-Berestein G, Sheng J, Wong ST, Birrer MJ, Mok SC. Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance. The Journal of Clinical Investigation. PMID 29251630 DOI: 10.1172/Jci95200  0.219
2021 Zhu Y, Ferri-Borgogno S, Sheng J, Yeung TL, Burks JK, Cappello P, Jazaeri AA, Kim JH, Han GH, Birrer MJ, Mok SC, Wong STC. SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment. Cancers. 13. PMID 33917869 DOI: 10.3390/cancers13081777  0.212
2013 Yeung TL, Leung CS, Wong KK, Samimi G, Thompson MS, Liu J, Zaid TM, Ghosh S, Birrer MJ, Mok SC. TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment. Cancer Research. 73: 5016-28. PMID 23824740 DOI: 10.1158/0008-5472.Can-13-0023  0.209
2016 Yang L, Achreja A, Yeung TL, Mangala LS, Jiang D, Han C, Baddour J, Marini JC, Ni J, Nakahara R, Wahlig S, Chiba L, Kim SH, Morse J, Pradeep S, et al. Targeting Stromal Glutamine Synthetase in Tumors Disrupts Tumor Microenvironment-Regulated Cancer Cell Growth. Cell Metabolism. 24: 685-700. PMID 27829138 DOI: 10.1016/J.Cmet.2016.10.011  0.204
2018 Yeung TL, Tsai CC, Leung CS, Au Yeung CL, Thompson MS, Lu KH, Freedman RS, Birrer MJ, Wong KK, Mok SC. ISG15 Promotes ERK1 ISGylation, CD8+ T Cell Activation and Suppresses Ovarian Cancer Progression. Cancers. 10. PMID 30469497 DOI: 10.3390/cancers10120464  0.173
2019 Yeung TL, Leung CS, Yip KP, Sheng J, Vien L, Bover L, Birrer MJ, Wong STC, Mok SC. Anticancer immunotherapy by MFAP5 blockade inhibits fibrosis and enhances chemosensitivity in ovarian and pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31332047 DOI: 10.1158/1078-0432.CCR-19-0187  0.164
2021 Lan Y, Moustafa M, Knoll M, Xu C, Furkel J, Lazorchak A, Yeung TL, Hasheminasab SM, Jenkins MH, Meister S, Yu H, Schlegel J, Marelli B, Tang Z, Qin G, et al. Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion. Cancer Cell. PMID 34506739 DOI: 10.1016/j.ccell.2021.08.008  0.164
2014 Leung CS, Yeung TL, Yip KP, Pradeep S, Balasubramanian L, Liu J, Wong KK, Mangala LS, Armaiz-Pena GN, Lopez-Berestein G, Sood AK, Birrer MJ, Mok SC. Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential. Nature Communications. 5: 5092. PMID 25277212 DOI: 10.1038/Ncomms6092  0.162
2020 Kwan SY, Au-Yeung CL, Yeung TL, Rynne-Vidal A, Wong KK, Risinger JI, Lin HK, Schmandt RE, Yates MS, Mok SC, Lu KH. Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression. Cancers. 12. PMID 31906456 DOI: 10.3390/cancers12010118  0.158
2018 Yeung TL, Sheng J, Leung CS, Li F, Kim J, Ho SY, Matzuk MM, Lu KH, Wong STC, Mok SC. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer. Journal of the National Cancer Institute. PMID 29860390 DOI: 10.1093/jnci/djy097  0.155
2020 Hu W, Zhang L, Ferri-Borgogno S, Kwan SY, Lewis KE, Cun HT, Yeung TL, Soliman PT, Tarapore RS, Allen JE, Guan X, Lu KH, Mok SC, Au-Yeung CL. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. Cancers. 12. PMID 32867127 DOI: 10.3390/Cancers12092436  0.148
2020 Au-Yeung CL, Yeung TL, Achreja A, Zhao H, Yip KP, Kwan SY, Onstad M, Sheng J, Zhu Y, Baluya DL, Co NN, Rynne-Vidal A, Schmandt R, Anderson ML, Lu KH, et al. ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment. Nature Communications. 11: 3546. PMID 32669559 DOI: 10.1038/S41467-020-17383-2  0.145
2015 Yeung TL, Leung CS, Yip KP, Au Yeung CL, Wong ST, Mok SC. Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis. American Journal of Physiology. Cell Physiology. 309: C444-56. PMID 26224579 DOI: 10.1152/ajpcell.00188.2015  0.138
2015 Yeung T, Chai J, Li R, Lee V, Ho PC, Ng E. A double-blind randomised controlled trial on the effect of dehydroepiandrosterone on ovarian reserve markers, ovarian response and number of oocytes in anticipated normal ovarian responders. Bjog : An International Journal of Obstetrics and Gynaecology. PMID 26663817 DOI: 10.1111/1471-0528.13808  0.129
2014 Li X, Nadauld L, Ootani A, Corney DC, Pai RK, Gevaert O, Cantrell MA, Rack PG, Neal JT, Chan CWM, Yeung T, Gong X, Yuan J, Wilhelmy J, Robine S, et al. Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture Nature Medicine. 20: 769-777. PMID 24859528 DOI: 10.1038/Nm.3585  0.129
2011 Zaid TM, Thompson M, Wong K, Yeung T, Yeung Z, Gershenson DM, Birrer MJ, Mok SC. Fibroblast growth factor receptor 4 (FGFR4) expression as a prognostic indicator in high-grade serous ovarian carcinoma (HGSC): Signaling pathway, mechanism, and implication for therapeutic targeting. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 5049. PMID 28023702 DOI: 10.1200/jco.2011.29.15_suppl.5049  0.121
2016 Lo CM, Lo JC, Sato PY, Yeung TL, Mok SC, Yip KP. Monitoring of ovarian cancer cell invasion in real time with frequency-dependent impedance measurement. American Journal of Physiology. Cell Physiology. ajpcell.00211.2016. PMID 27784677 DOI: 10.1152/ajpcell.00211.2016  0.117
2013 Zaid TM, Yeung TL, Thompson MS, Leung CS, Harding T, Co NN, Schmandt RS, Kwan SY, Rodriguez-Aguay C, Lopez-Berestein G, Sood AK, Wong KK, Birrer MJ, Mok SC. Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 809-20. PMID 23344261 DOI: 10.1158/1078-0432.Ccr-12-2736  0.104
2017 Rynne-Vidal A, Au-Yeung CL, Jiménez-Heffernan JA, Pérez-Lozano ML, Cremades-Jimeno L, Bárcena C, Cristóbal-García I, Fernández-Chacón C, Yeung TL, Mok SC, Sandoval P, López-Cabrera M. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer. The Journal of Pathology. PMID 28247413 DOI: 10.1002/path.4889  0.104
2010 Yiu WH, Yeung TL, Poon JW, Tsui SK, Fung KP, Waye MM. Transcriptional regulation of IER3IP1 gene by tumor necrosis factor-alpha and Sp family proteins. Cell Biochemistry and Function. 28: 31-7. PMID 19885854 DOI: 10.1002/Cbf.1613  0.092
2022 Lan Y, Yeung TL, Huang H, Wegener AA, Saha S, Toister-Achituv M, Jenkins MH, Chiu LY, Lazorchak A, Tarcic O, Wang H, Qi J, Locke G, Kalimi D, Qin G, et al. Colocalized targeting of TGF-β and PD-L1 by bintrafusp alfa elicits distinct antitumor responses. Journal For Immunotherapy of Cancer. 10. PMID 35858707 DOI: 10.1136/jitc-2021-004122  0.09
2016 Au Yeung CL, Co NN, Tsuruga T, Yeung TL, Kwan SY, Leung CS, Li Y, Lu ES, Kwan K, Wong KK, Schmandt R, Lu KH, Mok SC. Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. Nature Communications. 7: 11150. PMID 27021436 DOI: 10.1038/ncomms11150  0.085
2022 Zhang L, Au-Yeung CL, Huang C, Yeung TL, Ferri-Borgogno S, Lawson BC, Kwan SY, Yin Z, Wong ST, Thomas V, Lu KH, Yip KP, Sham JSK, Mok SC. Ryanodine receptor 1-mediated Ca signaling and mitochondrial reprogramming modulate uterine serous cancer malignant phenotypes. Journal of Experimental & Clinical Cancer Research : Cr. 41: 242. PMID 35953818 DOI: 10.1186/s13046-022-02419-w  0.077
2013 Ellis CE, Vulesevic B, Suuronen E, Yeung T, Seeberger K, Korbutt GS. Bioengineering a highly vascularized matrix for the ectopic transplantation of islets Islets. 5: 216-225. PMID 24262950 DOI: 10.4161/Isl.27175  0.062
2016 Yeung TL, Leung CS, Li F, Wong SS, Mok SC. Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment. Biomolecules. 6. PMID 26751490 DOI: 10.3390/biom6010003  0.058
2014 Yeung TL, Leung CS, Mok SC. CAF reprogramming inhibits ovarian cancer progression. Cell Cycle (Georgetown, Tex.). 13: 3783-4. PMID 25483059 DOI: 10.4161/15384101.2014.988106  0.056
2015 Buchs NC, Nicholson GA, Yeung T, Mortensen NJ, Cunningham C, Jones OM, Guy R, Hompes R. Transanal rectal resection: an initial experience of 20 cases. Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland. PMID 26639062 DOI: 10.1111/codi.13227  0.039
2012 Cortelyou-Ward K, Swain A, Yeung T. Mitigating error vulnerability at the transition of care through the use of health IT applications Journal of Medical Systems. 36: 3825-3831. PMID 22527783 DOI: 10.1007/S10916-012-9855-X  0.029
2021 Hu W, Zhang L, Ferri-Borgogno S, Kwan SY, Lewis KE, Cun HT, Yeung TL, Soliman PT, Tarapore RS, Allen JE, Guan X, Lu KH, Mok SC, Au-Yeung CL. Correction: Hu, W., et al. Targeting Dopamine Receptor D2 by Imipridone Suppresses Uterine Serous Cancer Malignant Phenotype. 2020, , 2436. Cancers. 13. PMID 33557446 DOI: 10.3390/cancers13040623  0.025
2015 Ris F, Yeung T, Hompes R, Mortensen NJ. Enhanced Reality and Intraoperative Imaging in Colorectal Surgery Clinics in Colon and Rectal Surgery. 28: 158-164. DOI: 10.1055/s-0035-1555007  0.024
2012 Barraez R, Yeung T. Engineering analysis of hand union connections in coiled tubing operations Proceedings - Spe Annual Technical Conference and Exhibition. 3: 1750-1765.  0.014
2014 Swarbrick K, Allin B, Yeung T, Sampson M. Enterolithotomy for the treatment of large bowel obstruction secondary to gallstones Bmj Case Reports. 2014. DOI: 10.1136/bcr-2014-208167  0.014
2012 Zouch M, Yeung T, Castanier B. Bayesian updating for road maintenance optimization 11th International Probabilistic Safety Assessment and Management Conference and the Annual European Safety and Reliability Conference 2012, Psam11 Esrel 2012. 1: 32-40.  0.01
2015 Fottler MD, Yeung T. Customer service Handbook of Healthcare Management. 98-126. DOI: 10.4337/9781783470167.00009  0.01
2015 El Hajj B, Schoefs F, Castanier B, Yeung T. A condition-based deterioration model for the crack propagation in a submerged concrete structure Safety and Reliability: Methodology and Applications - Proceedings of the European Safety and Reliability Conference, Esrel 2014. 2193-2199.  0.01
2014 Lim CKB, Yeung VSY, Yeung TL, Tam ACY, Ho CSH, Wong SWL, Chow BWY, Ho YM, Chou CHN, Fung CHF, Wong CF, Waye MMY. Genotype analyses using SNP (using Maldi-Tof mass spectrometry) and STR (microsatellite) markers in the determination of zygosity status of Chinese Twins Biochemistry and Molecular Biology Coming of Age. 41-53.  0.01
2013 Dubedout H, Neagu N, Dejax P, Yeung T. Customer allocation and production optimization under plant outages Proceedings of 2013 International Conference On Industrial Engineering and Systems Management, Ieee - Iesm 2013 0.01
Hide low-probability matches.